Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 26 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $155K 1,375 sh | Apr 22, 2026 |
| 26 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $106K 900 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 26 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $83K 750 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 26 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $58K 515 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 26 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $83K 750 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 26 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $136K 1,218 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 24 | Kantrowitz IanDirector, VICE PRESIDENT, 10% Owner | Grant or award | A | — 1.50M sh | Apr 22, 2026 traded Dec 12, 2025 |
| 24 | Rigney Shannon LeeDirector, VICE PRESIDENT, 10% Owner | Grant or award | A | — 1.50M sh | Apr 22, 2026 traded Dec 12, 2025 |
| 24 | Hail JeffreyDirector, CHIEF OPERATING OFFICER, 10% Owner | Grant or award | A | — 1.50M sh | Apr 22, 2026 traded Dec 12, 2025 |
| 24 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $377K 61.3K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 23 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $51K 4,704 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 23 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $31K 282 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 23 | Capital V LLC10% Owner | Open-market sale · 10b5-1 plan | SELL | $90K 8,389 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 23 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $5.92M 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 23 | Smolyansky LudmilaMember of 10% owner group | Open-market sale | SELL | $398K 15.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 23 | Ahuja AmritaCFO & COO | Open-market sale · 10b5-1 plan | SELL | $2.32M 30.9K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 23 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $51K 4,704 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 23 | Capital V LLC10% Owner | Open-market sale · 10b5-1 plan | SELL | $154K 14.1K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 22 | Detz KevinEVP & Chief Financial Officer | Tax withholding | F | $144K 4,461 sh | Apr 22, 2026 traded Apr 5, 2026 |
| 22 | A-6684 Ltd.10% Owner | Open-market purchase | BUY | $3,110 4,064 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 22 | Ribar BrandonDirector, President & CEO | Tax withholding | F | $226K 7,010 sh | Apr 22, 2026 traded Apr 5, 2026 |
| 22 | Dorchak GlendaDirector | Open-market sale · 10b5-1 plan | SELL | $234K 4,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 22 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Open-market sale · 10b5-1 plan | SELL | $1.50M 33.3K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.70M 1.00M sh | Apr 22, 2026 traded Apr 22, 2026 |
| 21 | Sanche Jacques WolfDirector | Grant or award | A | — 2,976 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Cox Erin NealyDirector | Option exercise | M | — 50.5K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Gibson Dwight Audley KonradDirector | Tax withholding | F | $42K 740 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Wilbur Maria Cristina AlapagDirector | Grant or award | A | — 2,976 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Gibson Dwight Audley KonradDirector | Grant or award | A | — 2,976 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.82M 1.00M sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | O'Leary Angela MVP, Controller & Ch Acct Offcr | Grant or award | A | — 41.9K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 21 | Rivkin Robert S.Director | Tax withholding | F | $42K 740 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Downs David HendrickDirector | Grant or award | A | — 450 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Rangwala ReshmaEVP & Chief Medical Officer | Open-market sale | SELL | $4,014 449 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Rivkin Robert S.Director | Grant or award | A | — 2,976 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 21 | Roth Pellanda Katja NicoleDirector | Grant or award | A | — 2,976 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 20 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $30K 2,796 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 20 | Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA | Option exercise | M | $184K 5,000 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 20 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $30K 2,796 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 20 | Jeffrey John Ronald Jr.Director | Option exercise | M | $186K 5,000 sh | Apr 22, 2026 traded Apr 21, 2026 |